awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35072606-D0E84B62-183F-4D82-BF7B-3F386209AF60
Q35072606-D0E84B62-183F-4D82-BF7B-3F386209AF60
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35072606-D0E84B62-183F-4D82-BF7B-3F386209AF60
The benefit-to-risk balance of combining infliximab with azathioprine varies with age: a markov model.
P2860
Q35072606-D0E84B62-183F-4D82-BF7B-3F386209AF60
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35072606-D0E84B62-183F-4D82-BF7B-3F386209AF60
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ec86c23dd7f0ebb9711a73c304e1d2b4bcb4a4d0
P2860
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease.